Diagnoses Disease
105
5
8
52
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Research Maturity
52 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.0%
1 terminated out of 105 trials
98.1%
+11.6% vs benchmark
0%
0 trials in Phase 3/4
4%
2 of 52 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 52 completed trials
Clinical Trials (105)
HEARTBEAT-TROP. Polyethylene Glycol Precipitation to Unmask Macrotroponin
Optimizing Bronchopulmonary Cancer Screening
Socioeconomic Inequalities in the Diagnosis and Treatment of Colon and Ovarian Cancer in England Between 2016-2017
Artificial Intelligence for Highly Myopic Cataract
Evaluating a New Stool Based qPCR for Diagnosis of Tuberculosis in Children and People Living With HIV
Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases
Evaluation of Clinical Decision Support System-mPDia for Neurodegenerative Parkinsonism Using MRI Images
Measuring Skin Elasticity in Lymphedema Patients
Asthma Diagnosis Verified by Lung Function
Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers
GP Response to Decontextualised Risk
TB-CAPT EXULTANT - HIV
TB-CAPT CORE Truenat Trial
Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema
Can VI-RADS/ADC Accurately Stage Bladder Cancer??
TB-CAPT MTB/XDR Study
Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy
Detection of Lipoarabinomannan in Urine Evaluation of the STANDARDTMF TBLAMFIA and Its Impact on the Initial TB Diagnosis
Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer